DiaMedica Therapeutics Inc.
Profile
Mailing Address: c/o DiaMedica USA Inc.
Suite 260, Two Carlson Parkway
Minneapolis, Minnesota
55447
Head Office Address: c/o DiaMedica USA Inc.
Suite 260, Two Carlson Parkway
Minneapolis, Minnesota
55447
Contact Name: Donna Husemoller Principal Regulator: Manitoba
Business e-mail address: dhusemoller@diamedica.com Short Form Prospectus Issuer: Yes
Telephone Number: 763 496-5454 Reporting Jurisdictions: British Columbia, Alberta, Manitoba, Ontario, Quebec
Fax Number: 763 710-4456 Stock Exchange: TSX Venture
Date of Formation: Jan 21 2000 Stock Symbol: DMA
Jurisdiction Where Formed: Canada Auditor: KPMG LLP
Industry Classification: consumer products - biotechnology/pharmaceuticals General Partner:
CUSIP Number: 25253X Transfer Agent: Computershare Investor Services Inc.
Financial Year-End: Dec 31 Size of Issuer (Assets): Under $5,000,000


View This Company's Documents